Enguent Jean-Pierre
Vice President, R&DSS
- Shares
- 35,000
- Price
- $2.46
- Value
- $85,936
LAES
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$158,822
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$1,122,615
6 distinct insiders
Highlighted alerts
0
38 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
LAES overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
Enguent Jean-Pierre
Vice President, R&DSS
Enguent Jean-Pierre
Vice President, R&DSS
Enguent Jean-Pierre
Vice President, R&DSS
Enguent Jean-Pierre
Vice President, R&DSS
O'Hara John Charles
Chief Financial Officer
Moreira Carlos
Chief Executive Officer
Enguent Jean-Pierre
Vice President, R&DSS
O'Hara John Charles
Chief Financial Officer
Moreira Carlos
Chief Executive Officer
O'Hara John Charles
Chief Financial Officer
Moreira Carlos
Chief Executive Officer
O'Hara John Charles
Chief Financial Officer
Moreira Carlos
Chief Executive Officer
O'Hara John Charles
Chief Financial Officer
Moreira Carlos
Chief Executive Officer
Buonanno Franck Jean
Vice-President, Global Sales
Enguent Jean-Pierre
Vice President, R&DSS
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
Enguent Jean-Pierre
Vice President, R&DSS
O'Hara John Charles
Chief Financial Officer
Feuardent Moreira Andreas
Chief Innovation Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
Buonanno Franck Jean
Vice-President, Global Sales
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
O'Hara John Charles
Chief Financial Officer
Verjus Nathalie Claude Odile
Company Secretary
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 06, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 35,000 | $2.46 | $85,936 | |
| Sep 03, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 15,000 | $2.40 | $36,030 | |
| Aug 05, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 15,000 | $2.46 | $36,857 | |
| Jul 08, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 15,000 | $2.82 | $42,267 | |
| Jun 05, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 143 | $3.51 | $501.93 | |
| Jun 05, 2026 | Moreira Carlos Chief Executive Officer | Sale | 300 | $3.51 | $1,053 | |
| Jun 03, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 15,000 | $3.51 | $52,652 | |
| Jun 03, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 5,582 | $3.53 | $19,704 | |
| Jun 03, 2026 | Moreira Carlos Chief Executive Officer | Sale | 7,005 | $3.53 | $24,744 | |
| Jun 02, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $3.69 | $36,931 | |
| Jun 02, 2026 | Moreira Carlos Chief Executive Officer | Sale | 10,000 | $3.69 | $36,905 | |
| May 29, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $3.51 | $35,076 | |
| May 29, 2026 | Moreira Carlos Chief Executive Officer | Sale | 10,000 | $3.51 | $35,086 | |
| May 27, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 4,689 | $3.50 | $16,430 | |
| May 27, 2026 | Moreira Carlos Chief Executive Officer | Sale | 4,139 | $3.50 | $14,503 | |
| May 14, 2026 | Buonanno Franck Jean Vice-President, Global Sales | Sale | 20,000 | $2.90 | $58,000 | |
| May 06, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 15,000 | $3.13 | $46,998 | |
| Apr 24, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 5,250 | $2.91 | $15,259 | |
| Apr 23, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.88 | $28,800 | |
| Apr 22, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $3.06 | $30,561 | |
| Apr 21, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $3.04 | $30,378 | |
| Apr 20, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.79 | $27,879 | |
| Apr 17, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.72 | $27,210 | |
| Apr 16, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.69 | $26,947 | |
| Apr 09, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.08 | $20,820 | |
| Apr 08, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale | 15,000 | $2.20 | $32,976 | |
| Apr 08, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.20 | $21,984 | |
| Apr 07, 2026 | Feuardent Moreira Andreas Chief Innovation Officer | Sale | 10,000 | $2.31 | $23,100 | |
| Apr 07, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.14 | $21,382 | |
| Apr 06, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.42 | $24,173 | |
| Apr 02, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.45 | $24,532 | |
| Mar 31, 2026 | Buonanno Franck Jean Vice-President, Global Sales | Sale | 10,000 | $2.35 | $23,500 | |
| Mar 25, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.92 | $29,247 | |
| Mar 24, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.90 | $28,996 | |
| Mar 23, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $2.99 | $29,892 | |
| Mar 20, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $3.00 | $29,989 | |
| Mar 19, 2026 | O'Hara John Charles Chief Financial Officer | Sale | 10,000 | $3.02 | $30,188 | |
| Mar 18, 2026 | Verjus Nathalie Claude Odile Company Secretary | Sale | 5,000 | $3.03 | $15,129 |